Questions?

A New Category:

euroPLX stands for continuous business development and pharma deals, the world's first no-lecture, no-presentation, just business partnering conference since 1995. euroPLX is organised in periodic events which last several months each, culminating in a conference after an extensive period of partnering information exchange.

The video explains the euroPLX process.



Truly European...

Held in 19 European countries, euroPLX (EC registered trademark) is the only truly European Pharma Partnering Conference while at the same time the most global. For euroPLX the adjunct "euro" is a commitment which is taken very seriously by its organisers.

 


...And Absolutely Global!

On the other side, the "euro" in euroPLX conceals the fact that this pharma and biopharma partnering conference is more international than most of its rivals. More than 1,800 companies from more than 80 countries have been using this platform for business deals. On average, each euroPLX Partnering Conference sees companies from 43 countries, always from at least 4 continents of the world!

Most of your questions concerning the cycle process will be answered in the chapters below.

1. What is euroPLX?

What is euroPLX ?

Previously known as European Pharma License Exchange, euroPLX is an international negotiation platform for pharma and biopharma decision makers who are in charge of business development and licensing in and out of

  • approved patented or generic drugs (incl. biosimilars)
  • early to late stage (ph. I and up) drug developments
  • OTC drugs and dietary supplements
  • medical devices
  • technologies applicable to marketed drugs or late stage drug developments.

euroPLX is organised in periodic events which last several months each, culminating in a conference after an extensive period of partnering information exchange. Typical attendees include CEOs, owners of medium-sized drug producers, vice presidents, directors, managers with decision power, and some trainees.

euroPLX period feature a scope of collaborative agreements from development to licensing, marketing, promotion, and distribution.

In addition, attending companies frequently offer or look for R&D services, supporting technologies (drug delivery, medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.

The actual focus of each euroPLX period is determined by the participating companies’ business interests and is displayed as a "Dynamic Partnering Focus" on www.europlx.com as delegates submit the necessary data.

The frequency (3 times per year) of euroPLX provides a time-to-market oriented instrument to follow up on negotiations in a timely manner.


What is so special about euroPLX?

Their focus on people, purpose, and effectiveness:

  • Only Business Developers and Licensing Executives, or Brokers/Consultants with a clear mandate are accepted. Strictly no other participants.
  • Online business development starts right after registration and continues long after the conference.
  • Its conferences focus on business appointments only. No lectures, presentations, keynotes, and other distracting features.
  • With 25-30 pre-scheduled appointments per 2-day event, euroPLX Conferences are more efficient than other partnering events, resulting in higher effectiveness of our clients’ attendance.

2. Global Audience!

Is euroPLX just for European companies?

No, it isn't. euroPLX is truely global in scope with delegates from more than 80 countries having attended, from all over Europe, Africa, the Americas, Asia, Australia, and Oceania. The business between European and non-European companies is even given particular emphasis.


How come mainstream partnering events have a larger audience than euroPLX Partnering Conferences?

Because mainstream partnering events have no people focus: government people, consultants, head-hunters, investment bankers, press and other non-core audience are allowed to attend, taking away your time for serious, targeted collaboration business.

euroPLX is strictly limited to executives in charge of business development and licensing. Consultants/brokers with clear and proven mandates or investments in own products or developments are also admitted.

 
What if a person registers that does not belong to the core group of business development or licensing executives?

euroPLX will not accept the registration. An exception is made for license brokers or consultants if (a) they can prove that they have an ongoing mandate by a pharma client to in-license or out-license a product or technology, or (b) they have invested in own product rights which they seek to sell.


What if a delegate of a company other than pharma or biopharma registers?


If we receive an registration of a company that is unknown to us, we will verify the nature of its business. If we cannot find evidence that the company is a pharmaceutical or biopharmaceutical developer, manufacturer, wholesaler, distributor, intermediates supplier, or technology provider, euroPLX will regret not to accept the registration.

3. Pre-Conference Value

What if I’m not sure whether I’ll find suitable partners at euroPLX?

www.europlx.com displays a list of registered companies which is updated automatically. euroPLX user account holders can log in and search the available partnering information for keywords without registering for a conference; the system will display the nunber of hits.


As a registrant, how do I know what the other companies offer or look for, and how do they know what I offer or look for?


During the period prior to the conference all registered companies provide and exchange non-confidential partnering information on the business opportunities which they offer and/or look for. Registrants of a euroPLX period can access the “Other Delegates' Interests” through their own user accounts.


How can I access the business opportunities offered by the other delegates?

After confirmed registration and activated online access, registrants log in to www.europlx.com with their user account data to see the link to the "Other Delegates' Interests". The "Other Delegates' Interests" page lists all registered companies along with their partnering information as submitted by its delegates.

Interesting "Other Delegates' Interests" can be marked "Favourite". Later on, when you request your appointments, you have the option of displaying only marked companies for easier selection.


How can I choose my meeting partners and make sure that I meet my important choices?


euroPLX Partnering Conferences are the only partnering event that combines a priority-based selection which ensures the scheduling of important choices, with a subsequent ask-and-accept procedure that lets Registrants complete their schedules and fill gaps.

1. euroPLX Priority: The first phase starts right after the registration deadline. Registrants may select up to 12 priority meetings  and rank the choices according to importance.

Appointments that have been requested in the euroPLX Priority phase must be accepted by the other party (reciprocity rule), who can, however, ask the requesting delegate to verify the request and eventually withdraw it if it should turn out that there is no common basis for business.

2. euroPLX Run!: During the second phase, each Registrant has access to a working schedule and can request additional appointments in order to complete his or her schedule. This is done by an ask-and-accept procedure, i.e. the requested party is notified by an email from the system and can either accept or deny the request.

Up to 12 requests in the Priority phase, additional requests in the Run! phase, and the counter-requests of other companies make up an average of 25 to 30 scheduled appointments per participating company.


When will I be able to download my final
appointments schedule?

On the Thursday morning prior to the conference Registrants are notified by e-mail that their individual PDF schedules are ready for downloading.


Can I contact my meeting partners before I meet them?


Yes. euroPLX provides registrants with the opportunity to interact with others long before the conference, which is only the culminating point of the participants’ interaction. euroPLX provides registrants with several tools to communicate with the other registrants during the run-up to the conference and to manage their partnering objectives.


What about accommodation and travel costs?


Delegates are responsible for their own accommodation and travel costs. However, our hotel partners usually offer preferential rates until a cut-off date approx. 3-4 weeks before the event as specified in the "Fee and Conditions" of each euroPLX Partnering Conference.

4. Conference Structure

What is the duration of a euroPLX Partnering Conference, what time does it start and end?

The Partnering Conference provides a session time frame of 2 days, starting in the morning of the first day at 09:00h and ending in the afternoon of the second at 16:30h. See also the "Detailed Programme" in each euroPLX section.

A registrant's individual schedule, however, may start later and end earlier. Also, the euroPLX scheduling system is flexible as to consider a registrant's late arrival on the first day or early departure on the second day.

The Core Session, during which the presence of each registrant is required and obligatory, starts at 14:00h on the first day and ends at 12:00h on the second day.

Each one-on-one meeting last 30 minutes.


What about ad hoc contacts?


In addition to the “official” time frame, euroPLX provides an opportunity for informal and ad hoc contacts outside the regular session times, during lunch, dinner, etc. Meetings that have been arranged privately between participants are also supported by euroPLX services.


Are there lectures or company presentations at the euroPLX
Partnering Conferences?

No. euroPLX attendees predominantly believe that listening to presentations is a waste of time if they can have the same information online, and the details in personal encounters.

Therefore: no lectures, no presentations, just business.


Should I attend the Networking Dinner Buffet?


Highly recommended! It is included in the registration fee. Attendees say it’s just great. The euroPLX Networking Dinner Buffet (attire: business suit or smart casual) takes place in the evening of the first day and has become a renowned opportunity for informal contacts.


What if I have special meal requirements?


There is quite some variation between the hotels’ capabilities to cater for the meal requirements of different cultures. However, as a general rule, we order food which does not contain pork items and rarely any beef (just poultry and seafood). We also ask the hotel to label all dishes.

Vegetarian food is usually not much of a problem although the hotel personnel’s understanding of “vegetarian” may differ from what vegetarians are used to. Nevertheless, we aim to include up to 40% vegetarian items, which is not easy in typical meat-eating countries.

Kosher food is generally not much of a problem either provided it is ordered at least 10 days prior to the conference. Hotels are used to these requirements and order the food individually from an external, approved source.

In any case, if you have special meal requirements, please inform us well in advance.

5. We deliver...!

How does RauCon manage to meet 80 to 90% of all appointments requests?

RauCon is regularly able to accommodate 80 to 90% of all requests. This is achieved by a unique match-making and scheduling method, supported by an IT-based, proprietary partnering and scheduling system that RauCon has designed, developed and refined over the years.


Do companies really have more than 25-29 scheduled appointments plus those scheduled on-site, plus ad hoc meetings…? How is that possible?


The average of 25-30 scheduled appointments per company is made up by scheduling a Registrant's own requests plus the request of others to meet the Registrant.

Focus and balance are critical for a euroPLX Partnering Conference. Only if a focused group of attendees share the right information within a focused range of topics, there will be enough reason to discuss business. And, of course, offers and requests must be balanced. RauCon actively intervenes during the registration process, if and when these prerequisites are not met.

By the way, an average of 25-30 or more pre-scheduled appointments means that some companies have 30 or more by going without a lunch break…


Why do other partnering events have a much lower number of one-on-one appointments?


Because only few organisers take the trouble to go through the process of pre-conference match-making. And even if they do, the conference design and their scheduling methods are inadequate to accommodate that many appointments.

More information

Track Record

euroPLX (formerly The European Pharma License Exchange) was designed and established by RauCon in 1995. Today it is the world's most often held pharma partnering conference and the most important business development platform for many.

Results Statistics

Statistics. Proof that value had been delivered

RauCon Partnering Conferences continues to lead the way in pharma partnering: 16,643 pre-scheduled business negotiations in addition to several ad hoc meetings at each of the three euroPLX Partnering Conferences that were held in 2018 in Lisbon (Portugal), Noordwijk (The Netherlands), and Athens (Greece).

Attendees of RauCon Partnering Conferences keep on returning again and again:

  • 213 companies have attended 10 times or more often
  • 39 companies have attended 9 times
  • 24 companies have attended 8 times
  • 49 companies have attended 7 times
  • 51 companies have attended 6 times
  • 99 companies have attended 5 times
  • 124 companies have attended 4 times
  • 191 companies have attended 3 times
  • 324 companies have attended twice

 

Companies who attended previously

euroPLX 70 Berlin (Germany) June 3 + 4, 2019

Companies From 42 Countries Were Registered:

2care4 Generics Aps, AAA Pharma GmbH, Abc Farma / Direct Salud S.L., Abigo Medical AB, Accel Pharma Inc, Accord Healthcare, Accord Healthcare MENA, Acic Europe Limited, Adamed Pharma S.A., Adoh BV, Advanz Pharma, Aflofarm Farmacja Polska, Alfred E. Tiefenbacher GmbH & Co. KG, Alkaloid AD Skopje, Alpha-medical d.o.o., Alvogen ehf., American Regent, Anfarm SA, Apotex Inc., Arrow Génériques, Artesan Pharma GmbH, Athena, Aurobindo Pharma Ltd, Aurovitas  S.A.U., AV Medical, Axelis Healthcare, S.L., axunio Pharma GmbH, Baxter, Bayer Consumer Care AG, Bharat Serums and Vaccines Ltd, Biocon Ltd, Biogaran, Biomed AG, Bioprojet Deutschland GmbH, Biose, Bluepharma Industria Farmaceutica SA, Brassica Pharma Pvt Ltd, Brill Pharma Sl, Cadila Pharmaceuticals Ltd, Calmino Group AB, Cell Biotech International A/S, Centrient Pharmaceuticals, Chanelle Medical Ltd., Chemineau, Chiesi , Cipla (EU) Limited, CTS Ltd., Curalife Ltd, Curida, Danhson-BG Ltd, Denk Pharma GmbH & Co. KG, Deva Holding A.S., Dexcel Pharma, Disproquima, Douglas Pharmaceuticals Limited, Dr. Kade Pharmazeutische Fabrik GmbH, Dr. Max Pharma, DR Pharma S.A., Eladiet, Elpen Pharmaceutical Co Inc, Enaltec Labs Pvt. Ltd., Esteve Pharmaceuticals, S.A., Ethypharm SA, Eureco Pharma, Eva Pharma, Excella GmbH & Co.KG, Exeltis  GmbH, Fair-Med Healthcare AG, Farmak JSC, Farmasierra, Fidia Pharma, Flavine Europe GmbH, G. Pohl-Boskamp GmbH & Co. KG, Galenicum Health, GAP S.A., Geiser Pharma, S.L., Genepharm S.A., Genericon Pharma Ges.m.b.H, GeneriNobel GmbH, Genetic SpA, George Medicines, Giellepi S.p.a., Green Swan Pharmaceuticals, Grünenthal GmbH, Grupo Profarmaco, GxMed Healthcare, Helm AG, Hetero Europe S.L., Hypera Pharma, Inceptua S.A., Innovis Pharma, INPHARMA S.p.A, Intas Pharmaceuticals Ltd., Inventia Healthcare Private Limited, Jamp Pharma Corp., Juno Pharmaceuticals Inc, Kéri Pharma Group, Labiana Pharmaceuticals, Laboratoire Aguettant, Laboratoire CCD, Laboratoires Gilbert, Laboratoires Urgo Healthcare, Laboratorios Alter S.A., Laboratorios Ordesa, S.L., Laboratorios Tillomed , Laboserve SA, L-A-W Services GmbH, LETI Pharma GmbH, Lunaria spol. s r.o., MAPBiopharma, Medichem S.A., Medicom Healthcare, Medis, d.o.o., Medis ehf., Medochemie Ltd., Medpharm, MedServa GmbH, Micro Labs GmbH, Midas Pharma GmbH, Morningside Healthcare Ltd, MSN Laboratories Europe Limited, Naprod Life Sciences, Neogen N.V., Neosante Health Solutions, SA, Neuraxpharm, Niche Generics Ltd, Nirial Pharma Srl, Nitto Pharmaceutical Industries, Ltd, Nordic Prime, Normon, Noventure, Orifarm Generics A/S, OtCEM Pharmaceuticals SL, PanGenerika B.V., Perffarma, Pharma International Company, PharmaMatch B.V., Pharmathen UK Ltd., Pharmavit APS, Pharmazac, Pharmex Advanced Laboratories S.L., Pharmex S.A., PharOS Ltd., PharOS Polska Sp. z o.o., Pizeta Pharma SpA, Probi AB, Procaps S.A., Repha GmbH, Riemser Pharma GmbH, Rontis, Rosemont Pharmaceuticals Ltd - Perrigo Plc, Rosesta Medical BV, R-Pharm  GmbH, Sandoz, Sandoz International GmbH, SanoSwiss UAB, Sanzyme Private Limited, Seid S.A., Servier CDMO, Shenzhen Beimei Pharmaceutical, S-Lab, S&R Farmaceutici S.p.a., Sérélys Pharma, Stada Arzneimittel AG, Steril-Gene Life Sciences Pvt Ltd, Substipharm, Sun Pharmaceutical Industries (Europe) BV, SymPhar Sp. z.o.o., Synchrony Pharma Ltd, Synthon BV, Tabuk Pharmaceuticals, TBD-Biodiscovery, Tedec-Meiji Farma, S.A., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals SRL, Tillomed Laboratories Ltd, Tolmar International Ltd, Torrent Pharma GmbH, Torrent Pharmaceuticals Ltd., Umedica Labs Pvt Ltd, Unipharm Ltd., Unison Pharmaceuticals Pvt Ltd, Unither Pharmaceuticals, Unolab Manufacturing, Veeda Clinical Research, Velit Biopharmaceuticals GmbH, V-Ensure Pharma Technologies Pvt. Ltd., Venture Life Limited, Will-Pharma b.v., Winclove Probiotics B.V., Wooshin Labottach Co., Ltd., Yiling Pharmaceutical Ltd., Zambon Spa, Zentiva Group a.s., Zentiva Pharma GmbH, Zentiva , Zinereo Pharma

euroPLX 69 London (UK) February 25 + 26, 2019

Companies From 47 Countries Were Registered:

Abc Farma / Direct Salud S.L., Abdi Ibrahim İlaç, Abdi Ibrahim Pharmaceuticals, Abiogen Pharma S.p.A., Accel Pharma Inc, Accord Healthcare, Acdima Biocenter, ACE Pharmaceuticals BV, Acino International AG, actrevo GmbH, Adamed Pharma S.A., Adcock Ingram Limited, Adoh BV, Advanz Pharma, Aflofarm Farmacja Polska, AJ Research & Pharma Sdn Bhd, AlbyPharma , Aldl Consulting Srls, Aldo-Unión, S.L., Alembic Pharmaceuticals Ltd., Alissa Healthcare Research Limited, Alkaloid AD Skopje, Allergika Pharma GmbH, Alpha-medical d.o.o., Alrazi Pharma, Alvogen, Alvogen ehf., Alwatan Arabian, Amneal UK, Anfarm SA, Angelini Farmaceutica S.A., Annahdah Medical Co., Antibiotice S.A., Apic, AqVida GmbH, Ardena, Aristo Pharma GmbH, Artesan Pharma GmbH, A.R.Z Asia, Aspen Pharma Brazil, Aspen Pharmacare (Pty) Ltd, Aspire Pharma Limited, Athena, Aurobindo Pharma Ltd, AV Medical, Axelis Healthcare, S.L., axunio Pharma GmbH, Basic Pharma, Biocon Ltd, Biofabri S.L., Biofarm Sp. Z.o.o., Biogaran, Biological E Limited, Bluepharma Genericos, Bluepharma Industria Farmaceutica SA, BMG Pharma SpA, Brassica Pharma Pvt Ltd, Brixon Pharma, Cadila Pharmaceuticals Ltd, Calmino Group AB, Cantabria Labs, Cantabria Labs - Nutrición Medica, Capricorn Life Sciences b.v., Carbet Medica, Centrient Pharmaceuticals, Chanelle Medical Ltd. , Chemi S.p.A., Chemineau, Chia Tai Tianqing Pharmaceutical (CTTQ), Chiesi Ltd, Cipla Ltd, Clinigen, Cole Pharmaceuticals, Consilient Health Limited, Coripharma ehf, Curalife Ltd, Curida, Cyndea Pharma, DCS Pharma AG, Delta Pharma-Al, Deva Holding A.S., Dexcel Pharma, Difass International Srl, Disphar International B.V., Doc Generici S.r.l., Dotcare Global Inc., Dr. Kade Pharmazeutische Fabrik GmbH, Dr. M. Newzella GmbH, Dr. Max Pharma, Dr. Reddy's Laboratories, Drossapharm AG, Edicta Pharm d.o.o., Egis Pharmaceuticals PLC , Elpen Pharmaceutical Co Inc, E-Pharma Trento S.p.A., EQL Pharma AB, Erfa Canada 2012 Inc, Ethypharm SA, Ethypharm UK, Europharm SMC, Eva Pharma, Eytelia, FAES Farma, S. A., Fair-Med Healthcare AG, Famar, Fareva, Farmak JSC, Farmaprojects S.A. / Polpharma B2B, Farmasierra, Finefoods & Pharmaceuticals Spa, Finoso Pharma Private Limited, Fresenius Kabi, Fresenius Kabi Deutschland GmbH, Galenicum Health, GAP S.A., Gebro Pharma, S.A., Geiser Pharma, S.L., Genepharm S.A., Giellepi S.p.a., G.L. Pharma GmbH, Glenmark Pharmaceuticals Limited, Goodwill Pharma Ltd. , GP Pharm SA, Guangzhou Chuangxiang Biomedical Technology Co., Ltd., Guangzhou Greensyn Pharma Co., Ltd, GxMed Healthcare, Hanmi Pharm. Co Ltd., Harvest Moon Pharmaceuticals USA, Inc., Hasco-Lek S.A., Healthwatchswiss A.G., Hennig Arzneimittel GmbH & Co. KG, Hetero Europe S.L., Hikma Pharmaceuticals, HK Pharma, Holsten Pharma GmbH, Humana Pharma International, Idifarma, Inbiotech Ltd, Ind Swift Limited, InfectoPharm, Intas Pharmaceuticals Ltd., Interquim, S.A., Inventia Healthcare Private Limited, Ipca Laboratories Ltd., Italfarmaco Spa, IV&C International Venture and Consulting, Jamp Pharma Corp., JGL d.d., Johnson Matthey, Jubilant Generic Ltd, Kent Pharmaceuticals, Kern Pharma, S.L., Kéri Pharma Group , Kyongbo Pharmaceutical Co., Ltd., Laboratoire Ccd, Laboratoires Grand Fontaine, Laboratoires Urgo Healthcare, Laboratorios Alter S.A., Laboratorios Basi S.A., Laboratorios Lesvi, Laboratorios Leti, S.L.U., Laboratorios Rubió, S.A., Laboratorios Salvat, S.A., Laboserve SA, Laurus Labs, LETI Pharma GmbH, Lexon UK, Liberty Pharma, Lo.Li. Pharma International Srl, Lunan Pharmaceutical Group Co, Ltd., Lunaria spol. s r.o., Lupin (Europe) Limited, Luye Pharma, Macleods UK Ltd, Mantra Pharma, Manx Healthcare Ltd, Masters Speciality Pharma, Maxmind Pharmaceuticals, Medac GmbH, Medichem S.A., Medicom Healthcare, Medis ehf., Medochemie Ltd., Medreich Plc, Medsurge Healthcare, Mega Lifesciences Pvt. Ltd., Miat S.p.A., Midas Pharma GmbH, Milltons Ltd, Mistral Capital Management Limited, Mitelos Bioscience, SL, Mithra Pharmaceuticals, Morningside Healthcare Ltd, MSN Laboratories Europe Limited, Napp Pharmaceuticals Limited, Natrapharm, Nectar Life Sciences Limited, Nemaura Pharma Limited, Neogen N.V., Neosanté Health Solution, Sa, Neuraxpharm, Normon, Noventure, Novick Biosciences, NTC s.r.l., Olive Healthcare, oncomed manufacturing a.s., Onko Ilac Sanayi Ve Ticaret A.s., Orifarm Generics A/S, OTC Medical BV, OtCEM Pharmaceuticals SL, Paladin Pharma S.p.a., PanGenerika B.V., Par Labs Europe, Perrigo, Pharma Line S.r.l., Pharma-Data SA, PharmaMatch B.V., Pharmascience Inc., Pharmaserve-Lilly SACI, Pharmatec Pakistan (Pvt) Ltd, Pharmathen UK Ltd., Pharmavit APS, Pharmax Pharmaceuticals, Pharmazac, Pharmex Advanced Laboratories S.L., PharOS Ltd., PHF SA, Pipelinepharma, Plameca, SA, PMV Life Science Pvt. Ltd., Precisionbiotics Ltd , Probi AB, Professional Dietetics International S.r.l., Quinta-Analytica, Rafarm UK Limited, Recipharm AB, Recordati İlaç San.ve Tic. A.Ş., Reig Jofre Group, Rekah, Ridge Pharma, Riverpharma Srl., Rivopharm UK Ltd, Rontis, Rosemont Pharmaceuticals Ltd, Rosemont Pharmaceuticals Ltd - Perrigo Plc, Salix S.r.l., Samon Ltd, Sandoz A/S Nordics, Sandoz International GmbH, Santa S.A., Sanzyme Private Limited, Seltfar Ltd, Spimaco, Stada Arzneimittel AG, Sterimax Inc., Sterling S.p.A., Strathos Pharma Group, Substipharm, Sun Pharmaceutical Industries (Europe) BV, Synoptis Pharma Sp. z o.o., Synthon BV, Tamarang SA, Tecnimede, S.A., Terapia - a Sun Pharma Comp., Teva Pharmaceuticals SRL, Teva UK and Ireland, Therakind Ltd, Tillomed Laboratories Ltd, Tolmar International Ltd , Torrent Pharma GmbH, Umedica Labs Pvt Ltd, Unilab, Inc., Unither Pharmaceuticals, Unolab Manufacturing, Uriach, Venture Life Limited, Verfora Ltd., Veriton Pharma Ltd., Vir, S.A., Welding GmbH & Co. KG, Will-Pharma b.v., Winclove Probiotics B.V., Xiromed, Zecare Limited

 

euroPLX 68 Athens (Greece) November 26 + 27, 2018

Companies From 36 Countries Were Registered:

Abdi Ibrahim İlaç, Abiogen Pharma S.p.A., Accel Pharma Inc, Accord Healthcare, Acdima Biocenter, AFCO SA, AJA Pharmaceutical Industries Company Limited, Alkaloid AD Skopje, Allergika Pharma GmbH, ALMA – Development, Manufacturing & Licensing of Medical Devices, Alpha-medical d.o.o., Alrazi Pharma, Alvogen ehf., Anfarm Sa, Anminh Pharma Company, Apotex Inc., Arac Healthcare, Ardena, Artesan Pharma GmbH, ASG Biochem Private Limited, Aspen Pharmacare (Pty) Ltd, Aurobindo Pharma Limited, Avia Pharma, Bene Arzneimittel GmbH, BioAvenir Ltd, Biological E Limited, BMG Pharma SpA, Capricorn Life Sciences b.v., Clinigen, CMS Medical Venture and A&B Fund, Concordia International Rx Limited, Conderco S.A., Conforma N.V., CTS Ltd., Curida, Demo Pharmaceuticals S.A., Deva Holding A.S., DKSH International, Douglas Pharmaceuticals Limited, Dr. Max Pharma, Dr. Reddy's Laboratories, DSM Sinochem Pharmaceuticals, Efarmes, S.A.U, Eladiet, Elpen Pharmaceutical Co Inc, Epione Labs Pvt. Ltd, Epsilon Health, Erfa  2012 Inc, Ethypharm SA, Ethypharm UK, Europharm Smc, Fareva, Farmak JSC, Fine Foods & Pharmaceuticals N.T.M. S.p.A., GAP S.A., Genepharm S.A., Generica Pharmaceuticals A.S., Genexo Sp. z o.o., Giellepi S.p.a., Gruppo Farmaimpresa Srl, GxMed Healthcare, Harvest Moon Pharmaceuticals USA, Inc., Helm AG, Hennig Arzneimittel GmbH & Co. KG, Hikma Pharmaceuticals, Hilton Pharma, Hisun Pharmaceutical Co., Ltd., InfectoPharm, Innovis Pharma, Inpha2000 Srl, Intas Pharmaceuticals Ltd., Inventia Healthcare Private Limited, JGL d.d., Labatec Pharma SA, Laboratoire Aguettant, Laboratoires Urgo Healthcare, Laboratorios Kin, S.A., Laboserve SA, Lamda Laboratories SA, Legacy Healthcare, Liberty Pharma, Lo.Li. Pharma International Srl, Lunaria spol. s r.o., Mantra Pharma, Manx Healthcare Ltd, Masters Speciality Pharma, Max Zeller Söhne AG, Medichem S.A., Medis, d.o.o., Medis ehf., Medochemie Ltd., Medreich Plc, Montefarmaco OTC, Morningside Healthcare Ltd, Napp Pharmaceuticals Limited, Nathura Spa, Neogen N.V., Neolojic, Nirial Pharma Srl, Normon, Noventure, OAHealth, Orifarm Generics A/S, Pharmabide Ltd, PharmaMatch B.V., Pharmathen Global B.V., Pharmavit APS, Pharmazac, Pharmex S.A., Phytopharm Klęka S.A., PMV Life Science Pvt. Ltd., Polpharma S.A., Procare Health, Professional Dietetics International S.r.l., Provident Pharmaceuticals, Queisser Pharma, RA Chem Pharma Ltd, Rafarm UK Limited, Remedica Ltd, Riemser Pharma GmbH, Rontis, Rosemont Pharmaceuticals Ltd - Perrigo Plc, R-Pharm  GmbH, Sanzyme Private Limited, Seid S.A., Shenzhen Beimei Pharmaceutical, SIA Unifarma, S.I.I.T. srl, Sofar Spa, SolPharma Ltd, Sterimax Inc., Substipharm Développement, Synchrony Pharma Ltd, Synthon BV, Torrent Pharma GmbH, Unither Pharmaceuticals, USV Private Limited, Venture Life Limited, Veriton Pharma Ltd., Vianex S.A., Winclove Probiotics B.V., Zentiva UK

 

euroPLX 67 Noordwijk (Netherlands) June 11 + 12, 2018

Companies From 40 Countries Were Registered:

Accel Pharma Inc, Accord Healthcare, Accord Healthcare MENA, Acino International AG, Adamed Sp. z o.o., Alissa Healthcare Research Limited, Allergika Pharma GmbH, Allgen Pharmaceuticals, ALMA – Development, Manufacturing & Licensing of Medical Devices, Alpha-medical d.o.o., Alvogen, American Regent, Antibiotice S.A., Apotex Inc., Ardena, Aristo Pharma GmbH, Armstrong Laboratorios de México, Aspen Pharmacare (Pty) Ltd, Athena, Aurex BV, Aurobindo Pharma Limited, Aurobindo Pharma Ltd, Azure Pharmaceuticals Ltd., Basic Pharma, Bausch & Lomb / Valeant, Beijing Sciecure Pharmaceutical Co., Ltd., Belupo d.d., Biofabri S.L., Biogaran, Biohit Oyj, Biomed AG, B-Medical B.V., Brown & Burk UK Ltd, Capricorn Life Sciences b.v., Cell Biotech International A/S, Chanelle Medical Ltd., Chemineau, ChemWerth, Cinnagen İlaç, Cipla Ltd, Concordia International Rx Limited, Curida, Dem Pharmaceuticals, Denk Pharma GmbH & Co. KG, Deva Holding A.S., Dexcel Pharma, Disphar International B.V., Douglas Pharmaceuticals Limited, Dr. Reddy's Laboratories, Dr. Reddy's Laboratories Inc, DSM Sinochem Pharmaceuticals, Edicta Pharm d.o.o., Eladiet, Elpen Pharmaceutical Co Inc, E-Pharma Trento S.p.A., EQL Pharma AB, Ethypharm SA, Eva Pharma, Exeltis Germany GmbH, Exeltis Pharmaceuticals, Extractumpharma Zrt., Fagron BV, Fair-Med Healthcare AG, Farmak a.s., Farmak JSC, Farmasierra, Fidia Pharma, Finefoods & Pharmaceuticals Spa, Focus Care Pharmaceuticals B.V., Ftf Pharma Pvt Ltd, Galenica S.A., Galenicum Health, GAP S.A., Geiser Pharma, S.L., Genepharm S.A., Generic Partners Pty Ltd, Genericon Pharma Ges.m.b.H, GeneriNobel GmbH, Genexo Sp. z o.o., Giellepi S.p.a., G.L. Pharma GmbH, Glenmark Pharmaceuticals Europe Limited, Global Pharmatech Private Limited, Grünenthal GmbH, GxMed Healthcare, Harvest Moon Pharmaceuticals USA, Inc., Heaton Group a.s., Helm AG, Hennig Arzneimittel GmbH & Co. KG, Hetero Europe S.L., Hisun Pharmaceutical Co., Ltd., InfectoPharm, Intas Pharmaceuticals Ltd., Interdos Pharma BV, Interquim, S.A., Inventia Healthcare Private Limited, Ipca Laboratories Ltd., JGL d.d., Julphar Gulf Pharmaceuticals, Juno Pharmaceuticals Inc, Kent Pharmaceuticals, Kyongbo Pharmaceutical Co., Ltd., Labatec Pharma SA, Labiana Pharmaceuticals, Labomar Srl, Laboratoire Aguettant, Laboratoires Grand Fontaine, Laboratoires Urgo Healthcare, Laboratorios Rubió, S.A., Laboserve, Labosuan, Lamda Laboratories SA, Laurus Labs, Legacy Healthcare, LETI Pharma GmbH, LN Pharma, LTS Lohmann Therapie-Systeme AG, Lupin (Europe) Limited, Manx Healthcare Ltd, Maxmind Pharmaceuticals, Medichem S.A./Combino Pharm, S.L., Medis, d.o.o., Medis ehf., Medochemie Ltd., MedServa GmbH, Micro Labs Limited, Midas Pharma GmbH, Minakem, Mistral Capital Management Limited, Mithra CDMO, Mithra Pharmaceuticals, MN Pharmaceuticals, Montefarmaco OTC, Mylan GmbH, Mylan SAS, Napp Pharmaceuticals Limited, Nathura Spa, Natrapharm, Neo Health (OTC) Pty Ltd, Neogen N.V., Normon, Novagen Pharma, Noventure, NTC s.r.l., Ofi, oncomed manufacturing a.s., Optimus Pharma Private Limited, Orfe, Orifarm Generics A/S, OtCEM Pharmaceuticals SL, Oystershell NV, PanGenerika B.V., Patheon, Part of Thermo Fisher Scientific, Perrigo Consumer Healthcare International, Pharma Line S.r.l., PharmaMatch B.V., Pharmamedic B.V., Pharmathen Global B.V., Pharmavit APS, Pharmaxima Srl, Pharmazac, Pharmex Advanced Laboratories S.L., Pharmex S.A., PharOS Ltd., PharOS Polska Sp. z o.o., Pipelinepharma, PMV Life Science Pvt. Ltd., Polpharma S.A., Precisionbiotics Ltd, Probi AB, Professional Dietetics International S.r.l., Recordati İlaç San.ve Tic. A.Ş., Reig Jofre Group, Rontis, Samon Ltd, Sandoz, Sanofi Pharmaceutical, Sanofi Turkey, Santa S.A., Sciecure Pharma Ltd, Shenzhen Beimei Pharmaceutical, Sofar Spa, So.Se.PHARM Srl, Stada Arzneimittel AG, Substipharm Développement, Summit Pharmaceuticals Europe, Sun Pharmaceutical Industries (Europe) BV, Sushen Medicamentos Pvt. Ltd., Synchrony Pharma Ltd, Synthon BV, Terapia - a Sun Pharma Comp., Teva Pharmaceutical Industries Ltd., Tillomed Italia S.r.l., Tillomed Laboratories Ltd, Tolmar International Ltd, Unipharm Ltd., Venture Life Limited, Veriton Pharma Ltd., Vinchem Europe, Welding GmbH & Co. KG, Will-Pharma b.v., Winclove Probiotics B.V., Wockhardt Bio AG, YDL Ventures Ltd., Zaltanpharma Laboratories, Zambon Switzerland Ltd, Zentiva Group, A.s., Zentiva (Sanofi Generics), Zenvision Pharma LLP

 

euroPLX 66 Lisbon (Portugal) March 5 + 6, 2018

Companies From 45 Countries Were Registered:

Abc Farma Internacional S.L., Abdi Ibrahim İlaç, Abiogen Pharma S.p.A., Accel Pharma Inc, Accord Healthcare, Accord Healthcare MENA, Acic Europe Limited, Acino International AG, Adamed Sp. z o.o., Adare Pharmaceuticals S.r.l., Adcock Ingram Limited, AJ Research & Pharma Sdn Bhd, Alembic Pharmaceuticals Ltd., Alfred E. Tiefenbacher GmbH & Co. KG, Alissa Healthcare Research Limited, Alkaloid AD Skopje, Alpha-medical d.o.o., Alvogen, AMG Labs, Amneal Pharmaceutical Co GmbH Switzerland, Amneal UK, Angelini Farmaceutica S.A., Annahdah Medical Co., Apotex Inc., APR Applied Pharma Research S.A., AqVida GmbH, Ardena, Arrow Génériques, A.R.Z Asia, A.R.Z Chemicals, Aspen Pharmacare (Pty) Ltd, Asphalion, S.l., Athena, Aurobindo Pharma Ltd, AV Medical, Avia Pharma, Axelis Healthcare, S.L., Basic Pharma, BioAvenir Ltd, Biocon Ltd, Biohit Oyj, Biological E Limited, Bluepharma Genericos, Bluepharma Industria Farmaceutica SA, BMG Pharma Srl, Cantabria Labs, Cantabria Labs - Nutrición Medica, Chanelle Medical Ltd., Chemi S.p.A., Chemineau, Chia Tai Tianqing Pharmaceutical (CTTQ), Chiesi, Colonis Pharma Ltd, Consilient Health Limited, Curida, Cyndea Pharma, Daewoong Pharmaceutical Co., Ltd., DCS Pharma AG, Deva Holding A.S., Develco Pharma Schweiz AG, Dexcel Pharma, Diater Laboratorios, Difass International Srl, Disphar International B.V., Doc Generici S.r.l., dotcare global, Dr. Kade Pharmazeutische Fabrik GmbH, Dr. M. Newzella GmbH, Dr. Max Pharma, Drogsan Pharmaceuticals, DSM Sinochem Pharmaceuticals, Edicta Pharm d.o.o., Efarmes, S.A.U, EG Labo, Egis Pharmaceuticals PLC, Elpen Pharmaceutical Co Inc, E-Pharma Trento S.p.A., EQL Pharma AB, Erfa Canada 2012 Inc, Esteve S.A., Ethypharm SA, Ethypharm UK, Eva Pharma, Eytelia, Fair-Med Healthcare AG, Fareva, Farmak JSC, Focus Care Pharmaceuticals B.V., Fresenius Kabi Deutschland GmbH, Frike Pharma AG, Ftf Pharma Pvt Ltd, Galenicum Health, GAP S.A., Geiser Pharma, S.L., Genepharm S.A., Genericon Pharma Ges.m.b.H (Austria, GeneVida GmbH, Giellepi S.p.a., G.L. Pharma GmbH, Glenmark Pharmaceuticals Europe Limited, Goodwill Pharma Ltd., GP Pharm SA, Guangzhou Greensyn Pharma Co., Ltd, GxMed Healthcare, Hanmi Pharm. Co Ltd., Harvest Moon Pharmaceuticals USA, Inc., Hasco-Lek S.A., Helm AG, Helm Portugal, Lda., Hermes Pharma, Hetero Europe S.L., Hikma Pharmaceuticals, Holsten Pharma GmbH, Idifarma, Ind Swift Limited, InfectoPharm, Inpha2000 Srl, Intas Pharmaceuticals Ltd., Interquim, S.A., Intertek (Schweiz) AG, Inventia Healthcare Private Limited, ISDIN, Jamp Pharma Corp., Juno Pharmaceuticals Inc, Kamedis Ltd, Kela Pharma, KelPharma Ltd, Kent Pharmaceuticals, Kern Pharma, S.L., Krewel Meuselbach GmbH, Kwizda Pharma GmbH, Laboratoires SMB S.A., Laboratoires Urgo Healthcare, Laboratorios Alter S.A., Laboratorios Basi S.A., Laboratorios Cinfa S.A., Laboratorios Farmaceúticos Rovi, S.A., Laboratorios Lesvi, Laboratorios Ordesa, Laboratorios Salvat, S.A., Laboratórios Atral SA, Laboratórios Azevedos, SA, Lamda Laboratories SA, Lácer S.A., Lexon UK, Liberty Pharma, Lo.Li. Pharma International Srl, Lunan Pharmaceutical Group Co, Ltd., Lupin (Europe) Limited, Macleods Pharmaceuticals Ltd., Macleods UK Ltd, MAPBiopharma, Masters Speciality Pharma, Mayoly-Spindler, Maypharm Life Sciences Pvt. Ltd., Medichem S.A./Combino Pharm, S.L., Medis, d.o.o., Medis ehf., Medochemie Ltd, MedServa GmbH, Medsurge Healthcare, Menarini/Berlin-Chemie AG, Miat S.p.A., Midas Pharma GmbH, Minakem, Mistral Capital Management Limited, Mithra Pharmaceuticals, Montavit GmbH, Montefarmaco OTC, Morningside Healthcare Ltd, MSN Laboratories Europe Limited, Nectar Life Sciences Limited, Neo Health (OTC) Pty Ltd, Neogen N.V., Niche Generics Ltd, Nirial Pharma Srl, Nordic Group BV, Normon, Noventure, Nutravis S.r.l., oncomed manufacturing a.s., OpenDoors Pharma, Opko, Orifarm Generics A/S, Paladin Pharma S.p.a., PanGenerika B.V., Pharmactive, PharmaMatch B.V., Pharmamedic B.V., Pharmascience Inc., Pharmathen UK Ltd., Pharmavit APS, Pharmax Pharmaceuticals (United Arab Emirates, PharOS Ltd., Pipelinepharma, Pizeta Group S.r.l., Polfarmex S.A., Probi AB, Procaps S.A., Pronova Laboratories, Pygen, Qualigen S.L., Queisser Pharma, Rafarm UK Limited, Recipharm, Recipharm AB, Reig Jofre Group, Riemser Pharma GmbH, Rivopharm UK Ltd, Rontis, R-Pharm Germany GmbH, Samon Ltd, Sandoz A/S, Sandoz International GmbH, Sandoz Portugal, Sandoz South Africa, Sandoz UK, Sanofi, Sanofi Aventis, Santa S.A., Seid S.A., Serrix bv, Servier CDMO, Shilpa Medicare Ltd, S.I.I.T. srl, SK Pharma, Slayback Pharma, SolPharma Ltd, Spimaco, Spirig Healthcare, Splendris Pharmaceuticals GmbH, Stada Arzneimittel AG, Strathos Pharma Group, Substipharm Développement, SymPhar Sp. z.o.o., Synoptis Pharma Sp. z o.o., Synthon BV, Tamarang Pharmaceuticals, Tecnimede, S.A., Tedec-Meiji Farma, S.A., Tillomed Laboratories Ltd, Tillomed Pharma GmbH, Torrent Pharma GmbH, Torrent Pharmaceuticals Ltd., Unipharm Ltd., Unither Pharmaceuticals, Unolab Manufacturing, Uriach, Valeo Pharma Inc, Venture Life Limited, Walmark, a.s., Welding GmbH & Co. KG, Xiromed, Zentiva Group a.s.

 

euroPLX 65 London (UK) November 27 + 28, 2017

Companies From 42 Countries Were Registered:

Abdİ İbrahİm, Abiogen Pharma S.p.A., Accord Healthcare, Aksuvital Dogal Urunler Gida Sanayi Ve Ticaret A.s., Alissa Healthcare Research Limited, Alpaya Dogal Ve Kozmetik Urunleri San Ve Tic Ltd, Alpha-medical d.o.o., Amneal UK, Apotex Inc., Aspen Pharmacare (Pty) Ltd, Athena, Aurobindo Pharma Ltd, Basic Pharma, Biohit Oyj, B-Medical B.V., BMG Pharma Srl, Cadila Pharmaceuticals Ltd, Chanelle Medical Ltd., Chemo Iberica, S.A., China Medical System Holdings, Clinical Network Services (UK) Ltd, Colonis Pharma Ltd, Conforma N.V., Consilient Health Limited, C-TRI, Curida, Custom Pharma Services, Daiichi Sankyo Brasil, Dekim Pharmaceuticals And Chemicals Inc, Delta Pharma-Al, DKSH Management (Thailand) Limited, Doublewing Pharma, Douglas Pharmaceuticals Limited, Dr. Max Pharma, Eladiet, Erfa Canada 2012 Inc, Fair-Med Healthcare AG, Fareva, Farmaprojects S.A., Finefoods & Pharmaceuticals Spa, FranceMed Pharma, Future Consultancy Ilac Ve Dıs Tic A.s., GBT Grupo Biotoscana, Genepharm S.A., GeneriNobel GmbH, Giellepi S.p.a., GM Bay SaĞlik Urunleri Ltd Sti, Guna Spa, GxMed Healthcare, Harman Finochem Ltd., Harvest Moon Pharmaceuticals USA, Inc., Helm AG, Hetero Europe S.L., Hikma Pharmaceuticals, InfectoPharm, Intech Biopharm, Inventia Healthcare Private Limited, JGL Russia, JGL d.d., Juno Pharmaceuticals Inc, Kent Pharmaceuticals, Krewel Meuselbach GmbH, Kyongbo Pharmaceutical Co., Ltd., Laboratoires Urgo Healthcare, Laboratorios Kin, S.A., Laboratorios Lesvi, Laboratorios Ordesa, Labosuan, LETI Pharma GmbH, Lexon UK, Liberty Pharma, Lo.Li. Pharma International Srl, Martin Dow Pharmaceuticals, Masters Speciality Pharma, Medapharm Healthcare, Medis ehf., Medochemie Ltd., MedServa GmbH, Methapharm Inc., Micro Labs Limited, Millmount Healthcare, Minakem, MN Pharmaceuticals, Morningside Healthcare Ltd, Named S.p.A., Napp Pharmaceuticals Limited, Nathura Spa, Nemaura Pharma Limited, Neogen N.V., Nirial Pharma Srl, Nitto Pharmaceutical Industries, Ltd, Normon, Novascon, Noventure, NTC s.r.l., Nutrilinea S.r.l., Nutrisens, Oncomed Manufacturing A.S., PanGenerika B.V., Par Laboratories Europe, Ltd, Pharmactive, Pharmargus Pharmaceuticals Research and Manufacturing Ind. and Foreign Trade Llc, Pharmavit APS, Polifarma Pharmaceuticals, Polpharma S.A., Probi AB, Proclin Pharma S.A., Professional Dietetics International S.r.l., Qualigen S.L., Rafarm UK Limited, Recordati İlaç San.ve Tic. A.Ş., Rosemont Pharmaceuticals Ltd - Perrigo Plc, Sager Pharma Kft, Sandoz Asia Pacific Regional Office, Sanofi Turkey, Santa S.A., Seid S.A., Servier CDM, S.I.I.T. srl, SolPharma Ltd, Sérélys Pharma, Substipharm Développement, SymPhar Sp. z.o.o., Synchrony Pharma Ltd, Synthon BV, Teva UK Limited, Tillomed Italia S.r.l., Titan Laboratories Pvt. Ltd., Trust Drug Store, Typharm Ltd, Unither Pharmaceuticals, Vefa İlaç Sanayi Ve Ticaret Limitid Şirketi, Venture Life Limited, Veriton Pharma Ltd., Winclove Probiotics B.V., Wooridul Pharmaceutical Ltd., Wooshin Labottach Co., Ltd., Zentiva UK

 

euroPLX 64 Vienna (Austria) May 29 + 30, 2017

Companies From 42 Countries Were Registered:

2care4 Generics ApS, Abdi Ibrahim İlaç, Accel Pharma Inc, Accord Healthcare (Spain), Accord Healthcare Ltd, Acino International AG, Acteaventures GmbH, AJ Research & Pharma Sdn Bhd, AJA Pharmaceutical Industries Company Limited, Alfred E. Tiefenbacher GmbH & Co. KG, Algol Pharma, Alissa Healthcare Research Limited, Alkaloid Skopje, Allgen Pharmaceuticals, Alpha-medical d.o.o., Ametas Medical GmbH, AOP Orphan Pharmaceuticals AG, Apipharma d.o.o., Apotex - In-Licensing, AqVida GmbH, ASA Pharma, Athena, Aurovitas Spain S.A.U., Avita Group of Companies, Basic Pharma, Bluefish Pharmaceuticals AB, Béres Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd, Chemineau, Chemo Iberica, S.A., China Medical System Holdings, Conforma N.V., Delorbis Pharmaceuticals Ltd, Demo Pharmaceuticals S.A., Deva Holding, Disphar, Doc Generici S.r.l., Douglas Pharmaceuticals Limited, Dr. Kade Pharma, Dr. Max Pharma Limited, Dr. Reddy's Laboratories, DSM Sinochem Pharmaceuticals, Edicta Pharm d.o.o., Efarmes, EirGen Pharma Ltd, Elpen Pharmaceutical Co Inc, Enaltec Labs Pvt. Ltd., Enorama Pharma, EQL Pharma AB, Ethypharm SA, Eytelia, FAES Farma, S. A., Fagron BV, Fair-Med Healthcare, Farmak a.s., Farmak JSC, Farmaprojects S.A. / Polpharma B2B, Finefoods & Pharmaceuticals Spa, Focus Care Pharmaceuticals B.V., Frike Pharma AG, G.L. Pharma GmbH, Galenicum Health, Geiser Pharma, S.L., Genepharm, Generica Pharmaceuticals A.S., Giellepi S.p.a., Glenmark Pharmaceuticals S.r.o., Goodwill Pharma, GxMed Healthcare, Harvest Moon Pharmaceuticals USA, Inc., Helm AG, Hennig Arzneimittel GmbH & Co. KG, Hetero Europe S.L., Idifarma, InfectoPharm, Intas Pharmaceuticals Ltd., Interquim, S.A., Intertek (Schweiz) AG, Inventia Healthcare Private Limited, Ipca Labs, Italfarmaco Spa, JGL d.d., Kent Pharmaceuticals, Kingchem Life Sciences Llc, Kwizda Pharma, Kyongbo Pharmaceutical Co., Ltd., Laboratoire Aguettant, Labosuan, Lamda Laboratories SA, Liberty Pharma, Lupin Europe, Macleods Pharmaceuticals Ltd., Martin Dow Pharmaceuticals, Medichem S.A./Combino Pharm, S.L., Medis ehf., Medochemie Ltd., MedServa GmbH, Miat S.p.A., Millmount Healthcare, Minakem, Montavit GmbH, Mundipharma Germany GmbH & Co. KG, Mylan UK, Mylan Spa, Named S.p.A., Napp Pharmaceuticals Limited, Neogen, Neolojic, Nirial Pharma Srl, Normon, NovaMedica, Noventure, NTC s.r.l., Omniactive Health Technologies, Opko, Orifarm Generics - Rx/Prescription, PanGenerika B.V., Pharma International Company, Pharmactive Pharmaceuticals, PharmaMatch B.V., Pharmatec Pakistan (Pvt) Ltd, Pharmavit APS, Pharmavize, PharmItbe Ltd, PharOS Ltd., PharOS Polska Sp. z o.o., Procaps S.A., Professional Dietetics International S.r.l., Quantum, R-Pharm Germany GmbH, Ratiopharm Arzneimittel Vertriebs GmbH, Reagena Oy Ltd, Recipharm AB, Reig Jofre Group, Rejsi Farma, Remedica Ltd, RN Laboratories AG, Rontis, RosenPharma, a.s., Rousselot BV, Samon Ltd, Sandoz Asia Pacific Regional Office, Sandoz International GmbH, Sanofi Aventis sp. z o.o., SastoMed GmbH, Sharp Clinical Services, SigmaPharm Laboratories International Ltd, SK Pharma, So.Se.PHARM Srl, Stada Arzneimittel AG, Stragen Pharmaceuticals, Strides Shasun Limited, Substipharm, Summit Pharmaceuticals Europe, Sun Pharma Global Fze, Sun Pharmaceutical Industries (Europe) BV, Synthon BV, Terapia - A Sun Pharma Comp., Tillomed Laboratories Ltd, Torrent Pharma (UK) Ltd, Unipharm Ltd., Unither Pharmaceuticals, Unolab Manufacturing, Urgo Healthcare, Venture Life, Vifor Consumer Health Ltd., Vir, S.A., VSL Pharmaceuticals Inc., Vésale Pharma, Walmark, a.s., Welding GmbH & Co. KG, Winclove Probiotics B.V., Xiromed, Zentiva (Sanofi Generics), Zentiva Group a.s.

 

About Us And euroPLX

euroPLX® (short for European Pharma License Exchange) is a Brainchild and Europe registered trademark of RauCon.

As a specialist consultancy for providing and organising collaborative opportunities, RauCon caters to international pharma and biopharma business development and licensing executives, with organisational tools for the optimisation of the business development process, advice, and career support.

Having organised partnering events in Europe, North America, and Australia since 1987, RauCon has pioneered the Pharma License Exchange concept in 1995, a novel business development platform for the pharmaceutical industry. Since then each single euroPLX Partnering Conference was meticulously planned and prepared by Dr. Norbert Rau and Mrs. Anke Rau who have an up-to-date perspective on the industry since three decades.

 

Dr. Norbert Rau and Mrs. Anke Rau

Their personal attention to detail and continuous innovation, and their focus on their customers' needs to achieve results have made euroPLX Partnering Conferences the recognised leader in partnering events with almost 17,000 facilitated partnering negotiations per year and an unmatched appointment-per-attendee ratio.


RauCon GmbH & Co. KG
Rudolf-Diesel-Str. 9
69115 Heidelberg
Germany

europlx@raucon.com


Tele-marketers: Please note that as a strict policy we do not place any orders following a cold call.

Legal/Impressum

Disclaimer

The information contained in this web site, and its associated web sites, including but not limited to RauCon, euroPLX and asiaPLX (hereinafter referred to as The Group), is provided as a service to the international pharma and biopharma business development community.

Reference herein to any specific commercial product, process, service, or trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, recommendation, or favouring by The Group.

With respect to documents available through this website, neither The Group nor its owners, nor any of its employees, make any warranty, express or implied, including the warranties of merchantability and fitness for a particular purpose, or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represent that its use would not infringe privately owned rights.

Credit card charges are settled through the following payment service provider: HUELLEMANN & STRAUSS ONLINESERVICES S.à r.l., 1, Place du Marché, L-6755 Grevenmacher, R.C.S. Luxembourg B 144133, E-Mail: info @ hso-services.com
CEO: Dipl. Vw. Mirko Hüllemann, Heiko Strauß, Ramona Spies

This website contains external hyperlinks to non-Group websites. A link to a non-Group website neither constitutes an endorsement by The Group of the linked web sites, or the information, products or services contained therein, nor does it cause The Group to be responsible for its content or the use of its content.


And, in order to satisfy German red tape:

Betreiberangaben nach §6 TDG:

RauCon GmbH & Co. KG • HRA Mannheim 707925 • Ust-ID-Nr. DE316466335
Pers. haft. Gesellschafter: RauCon Beteiligungs GmbH • HRB Mannheim 729230 •
Geschäftsführer: Dr. Norbert Rau, Anke Rau

Rudolf-Diesel-Str. 9
69115 Heidelberg, Germany
inform@raucon.com